[1]
Azariani, W. et al. 2025. In Silico Assessment of GSK-3? Inhibition Activity by Secondary Metabolites of Centella asiatica in the Development of Alzheimer’s Therapy. Journal of Tropical Pharmacy and Chemistry. 9, 2 (Dec. 2025), 64–70. DOI:https://doi.org/10.25026/jtpc.v9i2.671.